236 related articles for article (PubMed ID: 35037466)
21. Long noncoding RNA
Aboudehen K; Farahani S; Kanchwala M; Chan SC; Avdulov S; Mickelson A; Lee D; Gearhart MD; Patel V; Xing C; Igarashi P
J Biol Chem; 2018 Jun; 293(24):9388-9398. PubMed ID: 29716997
[TBL] [Abstract][Full Text] [Related]
22. Identification of pathological transcription in autosomal dominant polycystic kidney disease epithelia.
Friedrich S; Müller H; Riesterer C; Schüller H; Friedrich K; Wörner CL; Busch T; Viau A; Kuehn EW; Köttgen M; Hofherr A
Sci Rep; 2021 Jul; 11(1):15139. PubMed ID: 34301992
[TBL] [Abstract][Full Text] [Related]
23. Identification of targets of IL-13 and STAT6 signaling in polycystic kidney disease.
Olsan EE; West JD; Torres JA; Doerr N; Weimbs T
Am J Physiol Renal Physiol; 2018 Jul; 315(1):F86-F96. PubMed ID: 29513071
[TBL] [Abstract][Full Text] [Related]
24. Cyclin-Dependent Kinase 1 Activity Is a Driver of Cyst Growth in Polycystic Kidney Disease.
Zhang C; Balbo B; Ma M; Zhao J; Tian X; Kluger Y; Somlo S
J Am Soc Nephrol; 2021 Jan; 32(1):41-51. PubMed ID: 33046531
[TBL] [Abstract][Full Text] [Related]
25. Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease.
Seeger-Nukpezah T; Proia DA; Egleston BL; Nikonova AS; Kent T; Cai KQ; Hensley HH; Ying W; Chimmanamada D; Serebriiskii IG; Golemis EA
Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12786-91. PubMed ID: 23858461
[TBL] [Abstract][Full Text] [Related]
26. Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression.
Streets AJ; Magayr TA; Huang L; Vergoz L; Rossetti S; Simms RJ; Harris PC; Peters DJ; Ong AC
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F577-F588. PubMed ID: 28077374
[TBL] [Abstract][Full Text] [Related]
27. Use of targeted sequence capture and high-throughput sequencing identifies a novel PKD1 mutation involved in adult polycystic kidney disease.
Sha YK; Sha YW; Mei LB; Huang XJ; Wang X; Lin SB; Li L; Li P
Gene; 2017 Nov; 634():1-4. PubMed ID: 28870863
[TBL] [Abstract][Full Text] [Related]
28. Metformin induces lactate accumulation and accelerates renal cyst progression in Pkd1-deficient mice.
Chang MY; Tsai CY; Chou LF; Hsu SH; Yang HY; Hung CC; Tian YC; Ong ACM; Yang CW
Hum Mol Genet; 2022 May; 31(10):1560-1573. PubMed ID: 34957500
[TBL] [Abstract][Full Text] [Related]
29. cGAS Activation Accelerates the Progression of Autosomal Dominant Polycystic Kidney Disease.
Yoo M; Haydak JC; Azeloglu EU; Lee K; Gusella GL
J Am Soc Nephrol; 2024 Apr; 35(4):466-482. PubMed ID: 38247039
[TBL] [Abstract][Full Text] [Related]
30. XBP1 Activation Reduces Severity of Polycystic Kidney Disease due to a Nontruncating Polycystin-1 Mutation in Mice.
Krappitz M; Bhardwaj R; Dong K; Staudner T; Yilmaz DE; Pioppini C; Westergerling P; Ruemmele D; Hollmann T; Nguyen TA; Cai Y; Gallagher AR; Somlo S; Fedeles S
J Am Soc Nephrol; 2023 Jan; 34(1):110-121. PubMed ID: 36270750
[TBL] [Abstract][Full Text] [Related]
31. RNA helicase p68 inhibits the transcription and post-transcription of
Zhang L; Li LX; Zhou JX; Harris PC; Calvet JP; Li X
Theranostics; 2020; 10(18):8281-8297. PubMed ID: 32724471
[No Abstract] [Full Text] [Related]
32. Triptolide reduces cyst formation in a neonatal to adult transition Pkd1 model of ADPKD.
Leuenroth SJ; Bencivenga N; Chahboune H; Hyder F; Crews CM
Nephrol Dial Transplant; 2010 Jul; 25(7):2187-94. PubMed ID: 20139063
[TBL] [Abstract][Full Text] [Related]
33. Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.
Saigusa T; Bell PD
Physiology (Bethesda); 2015 May; 30(3):195-207. PubMed ID: 25933820
[TBL] [Abstract][Full Text] [Related]
34. Bialleleic PKD1 mutations underlie early-onset autosomal dominant polycystic kidney disease in Saudi Arabian families.
Al-Hamed MH; Alsahan N; Rice SJ; Edwards N; Nooreddeen E; Alotaibi M; Kurdi W; Alnemer M; Altaleb N; Ali W; Al-Numair N; Almejaish N; Sayer JA; Imtiaz F
Pediatr Nephrol; 2019 Sep; 34(9):1615-1623. PubMed ID: 31079206
[TBL] [Abstract][Full Text] [Related]
35. Novel mutations of PKD genes in Chinese patients suffering from autosomal dominant polycystic kidney disease and seeking assisted reproduction.
He WB; Xiao WJ; Tan YQ; Zhao XM; Li W; Zhang QJ; Zhong CG; Li XR; Hu L; Lu GX; Lin G; Du J
BMC Med Genet; 2018 Oct; 19(1):186. PubMed ID: 30333007
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of TGF-β1 induces renal fibrosis and accelerates the decline in kidney function in polycystic kidney disease.
Zhang Y; Dai Y; Raman A; Daniel E; Metcalf J; Reif G; Pierucci-Alves F; Wallace DP
Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1135-F1148. PubMed ID: 33166182
[TBL] [Abstract][Full Text] [Related]
37. A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with autosomal dominant polycystic kidney disease.
Ali H; Hussain N; Naim M; Zayed M; Al-Mulla F; Kehinde EO; Seaburg LM; Sundsbak JL; Harris PC
BMC Nephrol; 2015 Mar; 16():26. PubMed ID: 25880449
[TBL] [Abstract][Full Text] [Related]
38. Probenecid slows disease progression in a murine model of autosomal dominant polycystic kidney disease.
Arkhipov SN; Potter DL; Sultanova RF; Ilatovskaya DV; Harris PC; Pavlov TS
Physiol Rep; 2023 Apr; 11(7):e15652. PubMed ID: 37024297
[TBL] [Abstract][Full Text] [Related]
39. Autosomal dominant polycystic kidney disease: Disrupted pathways and potential therapeutic interventions.
Malekshahabi T; Khoshdel Rad N; Serra AL; Moghadasali R
J Cell Physiol; 2019 Aug; 234(8):12451-12470. PubMed ID: 30644092
[TBL] [Abstract][Full Text] [Related]
40. G-protein signaling modulator 1 deficiency accelerates cystic disease in an orthologous mouse model of autosomal dominant polycystic kidney disease.
Kwon M; Pavlov TS; Nozu K; Rasmussen SA; Ilatovskaya DV; Lerch-Gaggl A; North LM; Kim H; Qian F; Sweeney WE; Avner ED; Blumer JB; Staruschenko A; Park F
Proc Natl Acad Sci U S A; 2012 Dec; 109(52):21462-7. PubMed ID: 23236168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
